Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Burton Medicare “Fallback” Plan Would Allow HHS To Negotiate Rx Prices

Executive Summary

House Government Reform/Human Rights & Wellness Subcommittee Chairman Dan Burton's (R-Ind.) proposed alternative to passing a full Medicare prescription drug benefit would rely on the government's ability to negotiate prices to maintain affordability of the program

You may also be interested in...



Medicare Rx Discount Cards Will Appear By June As Bill Clears Final Hurdles

Medicare-endorsed prescription drug discount cards will enter the market by June

Medicare Rx Discount Cards Will Appear By June As Bill Clears Final Hurdles

Medicare-endorsed prescription drug discount cards will enter the market by June

Rx Pricing Plan Offered By FDA’s McClellan; Industry Must Meet “Challenge”

The pharmaceutical industry must "work harder" to establish equitable pricing models, FDA Commissioner McClellan declared during a Sept. 25 address to the First International Colloquium on Generic Medicine in Cancun, Mexico

Related Content

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel